We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Kinetic Variables Most Useful for Detecting Malignant MRI-Detected Breast Lesions

By HospiMedica International staff writers
Posted on 02 Sep 2009
Breast magnetic resonance imaging (MRI) allows clinicians to assess suspicious lesions using a variety of variables. More...
Researchers have revealed that computer-aided kinetic information can help considerably in distinguishing benign from malignant suspicious breast lesions on MRI.

In the study performed at the University of Washington Medical Center (Seattle, USA), researchers analyzed and compared the computer-aided evaluation variables of 125 suspicious breast lesions. Three different kinetic curves (washout, plateau, and persistent) were compared along with lesion morphology (size and shape).

"We wanted to clarify which of the many variables that reflect kinetics were most predictive of malignancy,” said Constance Lehman, M.D., lead author of the study. "We found overlap in kinetic patterns across benign and malignant lesions, but we did determine that the ‘most suspicious' curve type, washout, was useful in separating benign from malignant lesions,” said Dr. Lehman. "Of lesions with the most suspicious curve type [any washout], 45.7% were malignant compared with 20.0% with plateau and 13.3% with entirely persistent enhancement,” she said.

The study's findings were published in the September 2009 issue of the American Journal of Roentgenology (AJR). "We continue to study the specific features on MRI most predictive of breast cancer. We know that the morphology of the lesion is extremely important, but our study also supports the use of kinetic features in lesion assessment. The most suspicious curve, washout, does seem to help distinguish benign from malignant lesions,” said Dr. Lehman. "In breast MRI, it is important to know which variables are most important for predicting malignancy because they help us in determining whether or not a lesion needs to be biopsied or not,” she said.

Related Links:

University of Washington Medical Center




Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Heavy-Duty Wheelchair Scale
6495 Stationary
External Defibrillator
HeartSave Y | YA
Gynecological Examination Chair
arco-matic
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.